Koda Masahiko, Maeda Yoshiko, Matsunaga Yoshiko, Mimura Ken ichi, Murawaki Yoshikazu, Horie Yasushi
Second Department of Internal Medicine, Faculty of Medicine, Tottori University, Yonago, 683-8504, Tottori, Japan
Hepatol Res. 2003 Oct;27(2):163-167. doi: 10.1016/s1386-6346(03)00207-9.
We report a case involving well-differentiated hepatocellular carcinoma (HCC) developing to HCC with sarcomatous changes after radiofrequency ablation (RFA). In a cirrhotic patient with both hepatitis B surface antigen and hepatitis C virus RNA, a well-differentiated HCC with a diameter of 2 cm was detected in segment IV of the liver. A combination of transcatheter arterial embolization and percutaneous ethanol injection (PEI) was performed and, after 8 months, PEI was performed for recurrent tumors. Fifteen months after the first treatment, a recurrent tumor measuring 3.5 cm in diameter was detected in segment IV, which was demonstrated as well-differentiated HCC by tumor biopsy, and treated by RFA. Although the treated lesion was reduced to 2.5 cm in diameter 6 months after RFA, the tumor rapidly enlarged to 6 cm in diameter 2 months later and progressed to lymph node metastasis. Aspiration biopsy showed spindle-shaped sarcomatoid cells with positive staining for both vimentin and keratin. The patient died of HCC progression 10 months after RFA. Autopsy findings showed both sarcomatoid cells and trabecular HCC cells. The sarcomatoid cells had metastasized to the lymph nodes and distant organs. This is the first case illustrating a sarcomatous HCC after RFA. Of interest, RFA may be related to the development of sarcomatous HCC.
我们报告一例病例,该病例为一名肝硬化患者,其乙肝表面抗原和丙肝病毒RNA均呈阳性,肝脏IV段检测到一个直径2cm的高分化肝细胞癌(HCC)。对其进行了经导管动脉栓塞术和经皮乙醇注射(PEI)联合治疗,8个月后,对复发性肿瘤进行了PEI治疗。首次治疗15个月后,在IV段检测到一个直径3.5cm的复发性肿瘤,经肿瘤活检证实为高分化HCC,并接受了射频消融(RFA)治疗。尽管RFA治疗6个月后,治疗后的病灶直径缩小至2.5cm,但2个月后肿瘤迅速增大至直径6cm,并进展为淋巴结转移。穿刺活检显示梭形肉瘤样细胞,波形蛋白和角蛋白染色均为阳性。患者在RFA治疗10个月后死于HCC进展。尸检结果显示既有肉瘤样细胞又有小梁状HCC细胞。肉瘤样细胞已转移至淋巴结和远处器官。这是首例说明RFA后出现肉瘤样HCC的病例。有趣的是,RFA可能与肉瘤样HCC的发生有关。